oasis 3 semaglutide 50 mg of oral #semaglutide daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://ja.ma/41sPiYj FDA approves once-daily oral Wegovy®

Semaglutide increases the risk of diabetic retinopathy or may exacerbate its progression in patients with pre-existing diabetic retinopathy

This reduction in potency may mean that the medication does not provide the expected blood sugar management or weight loss benefits, which could be problematic for patients relying on consistent results

However, the incidence of gastrointestinal AEs was generally similar regardless of the background medication subgroup

When youve exhausted the options within a single-receptor medication, adding a second receptor pathway through tirzepatide gives your body a genuinely new stimulus to respond to

Figure 3 Colony PCR of E.Coli ToplO-pET24-His6-AV-Ubiquitin-Semapeptide Gene (clones) using T7 Primers

investigated the synergistic effects of MSTN inhibitors and GLP-1 agonists by administering apitegromab in combination with semaglutide, a GLP-1 agonist, and tirzepatide, a dual agonist of GLP-1 and glucose-dependent insulinotropic polypeptide, in patients with obesity (NCT06445075)